Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-obesity Prescription industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Zealand Pharma
Akrimax Pharmaceuticals
Arrowhead Research
Alpex Pharma
Bridge BioResearch
Arena Pharmaceuticals
Compellis Pharmaceuticals
Zydus Cadila
Yungjin Pharm
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
Application:
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Anti-obesity Prescription Industry Overview
-
1.1.1 Anti-obesity Prescription Market Scope and Market Segments
-
1.1.2 Anti-obesity Prescription Industry Characteristics
-
1.1.3 Global and China Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Anti-obesity Prescription Production Value and Growth Rate (2017-2028)
-
1.2 Global Anti-obesity Prescription Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Bupropion and Naltrexone
-
1.2.2 Orlistat
-
1.2.3 Lorcaserin
-
1.2.4 Phentermine and Topiramate
-
1.2.5 Liraglutide
-
1.3 Global Anti-obesity Prescription Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital Pharmacies
-
1.3.2 Retail Pharmacies
-
1.3.3 E-Commerce
-
1.4 Market Analysis by Region
-
1.4.1 North America Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Anti-obesity Prescription Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Anti-obesity Prescription Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Anti-obesity Prescription Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Anti-obesity Prescription Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Anti-obesity Prescription Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Anti-obesity Prescription Industry Porter's Five Forces Model Analysis
-
2.2.3 Anti-obesity Prescription Industry PEST Analysis
-
2.3 Anti-obesity Prescription Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Anti-obesity Prescription Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Anti-obesity Prescription Industry
Chapter 3 Global and China Anti-obesity Prescription Market, by Manufacturer
-
3.1 Global and China Anti-obesity Prescription Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Anti-obesity Prescription Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Anti-obesity Prescription Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Anti-obesity Prescription Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Anti-obesity Prescription Market Top 3 Players
Chapter 4 Global and China Anti-obesity Prescription Market, by Type (2017-2028)
-
4.1 Anti-obesity Prescription Market Trend, by Type
-
4.2 Global Anti-obesity Prescription Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Anti-obesity Prescription Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Anti-obesity Prescription Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Anti-obesity Prescription Price Trend, by Type (2017-2028)
-
4.3 China Anti-obesity Prescription Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Anti-obesity Prescription Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Anti-obesity Prescription Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Anti-obesity Prescription Price Trend, by Type (2017-2028)
Chapter 5 Global and China Anti-obesity Prescription Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Anti-obesity Prescription Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Anti-obesity Prescription Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Anti-obesity Prescription Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Anti-obesity Prescription Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Anti-obesity Prescription Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Anti-obesity Prescription Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Anti-obesity Prescription Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Anti-obesity Prescription Market Analysis
-
7.1 North America Anti-obesity Prescription Market, by Type
-
7.2 North America Anti-obesity Prescription Market, by Application
-
7.3 North America Anti-obesity Prescription Market Analysis and Forecast, by Country
-
7.3.1 United States Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Anti-obesity Prescription Market Analysis
-
8.1 Europe Anti-obesity Prescription Market, by Type
-
8.2 Europe Anti-obesity Prescription Market, by Application
-
8.3 Europe Anti-obesity Prescription Market Analysis and Forecast, by Country
-
8.3.1 Germany Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Anti-obesity Prescription Market Analysis
-
9.1 APAC Anti-obesity Prescription Market, by Type
-
9.2 APAC Anti-obesity Prescription Market, by Application
-
9.3 APAC Anti-obesity Prescription Market Analysis and Forecast, by Country
-
9.3.1 China Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Anti-obesity Prescription Market Analysis
-
10.1 Latin America, Middle East and Africa Anti-obesity Prescription Market, by Type
-
10.2 Latin America, Middle East and Africa Anti-obesity Prescription Market, by Application
-
10.3 Latin America, Middle East and Africa Anti-obesity Prescription Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Anti-obesity Prescription Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Anti-obesity Prescription Company Profiles
-
11.1 Zealand Pharma
-
11.1.1 Zealand Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Zealand Pharma Anti-obesity Prescription Product Profiles, Application and Specification
-
11.1.3 Zealand Pharma Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Akrimax Pharmaceuticals
-
11.2.1 Akrimax Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Akrimax Pharmaceuticals Anti-obesity Prescription Product Profiles, Application and Specification
-
11.2.3 Akrimax Pharmaceuticals Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Arrowhead Research
-
11.3.1 Arrowhead Research Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Arrowhead Research Anti-obesity Prescription Product Profiles, Application and Specification
-
11.3.3 Arrowhead Research Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Alpex Pharma
-
11.4.1 Alpex Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Alpex Pharma Anti-obesity Prescription Product Profiles, Application and Specification
-
11.4.3 Alpex Pharma Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Bridge BioResearch
-
11.5.1 Bridge BioResearch Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Bridge BioResearch Anti-obesity Prescription Product Profiles, Application and Specification
-
11.5.3 Bridge BioResearch Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Arena Pharmaceuticals
-
11.6.1 Arena Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Arena Pharmaceuticals Anti-obesity Prescription Product Profiles, Application and Specification
-
11.6.3 Arena Pharmaceuticals Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Compellis Pharmaceuticals
-
11.7.1 Compellis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Compellis Pharmaceuticals Anti-obesity Prescription Product Profiles, Application and Specification
-
11.7.3 Compellis Pharmaceuticals Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Zydus Cadila
-
11.8.1 Zydus Cadila Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Zydus Cadila Anti-obesity Prescription Product Profiles, Application and Specification
-
11.8.3 Zydus Cadila Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Yungjin Pharm
-
11.9.1 Yungjin Pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Yungjin Pharm Anti-obesity Prescription Product Profiles, Application and Specification
-
11.9.3 Yungjin Pharm Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Anti-obesity Prescription Industry Investment Prospect and Risk Assessment
-
12.1 Anti-obesity Prescription Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Anti-obesity Prescription Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Global Anti-obesity Prescription Production Value and Growth Rate (2017-2028)
-
Figure China Anti-obesity Prescription Production Value and Growth Rate (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of Bupropion and Naltrexone (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of Orlistat (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of Lorcaserin (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of Phentermine and Topiramate (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of Liraglutide (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of Hospital Pharmacies (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of Retail Pharmacies (2017-2028)
-
Figure Global Anti-obesity Prescription Market Size and Growth Rate of E-Commerce (2017-2028)
-
Figure North America Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-obesity Prescription Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Anti-obesity Prescription Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Anti-obesity Prescription Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Anti-obesity Prescription Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Anti-obesity Prescription Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Anti-obesity Prescription Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Anti-obesity Prescription Market Share, by Manufacturer in 2021
-
Figure Global and China Anti-obesity Prescription Market Share, by Manufacturer in 2022
-
Table Global Anti-obesity Prescription Sales Volume, by Type (2017-2028)
-
Table Global Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Figure Global Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Table Global Anti-obesity Prescription Sales Value, by Type (2017-2028)
-
Table Global Anti-obesity Prescription Sales Value Share, by Type (2017-2028)
-
Figure Global Anti-obesity Prescription Price Trend, by Type (2017-2028)
-
Table China Anti-obesity Prescription Sales Volume, by Type (2017-2028)
-
Table China Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Figure China Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Table China Anti-obesity Prescription Sales Value, by Type (2017-2028)
-
Table China Anti-obesity Prescription Sales Value Share, by Type (2017-2028)
-
Figure China Anti-obesity Prescription Price Trend, by Type (2017-2028)
-
Table Global Anti-obesity Prescription Sales Volume, by Application (2017-2028)
-
Table Global Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure Global Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Table Global Anti-obesity Prescription Sales Value, by Application (2017-2028)
-
Table Global Anti-obesity Prescription Sales Value Share, by Application (2017-2028)
-
Figure Global Anti-obesity Prescription Sales Value Share, by Application (2017-2028)
-
Table China Anti-obesity Prescription Sales Volume, by Application (2017-2028)
-
Table China Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Table China Anti-obesity Prescription Sales Value, by Application (2017-2028)
-
Table China Anti-obesity Prescription Sales Value Share, by Application (2017-2028)
-
Figure China Anti-obesity Prescription Sales Value Share, by Application (2017-2028)
-
Figure China Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
Figure North America Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Anti-obesity Prescription Production, Import, Consumption and Export (2017-2022)
-
Table North America Anti-obesity Prescription Sales Volume, by Type (2017-2028)
-
Table North America Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Figure North America Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Table North America Anti-obesity Prescription Sales Volume, by Application (2017-2028)
-
Table North America Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure North America Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure United States Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure United States Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Canada Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Table Europe Anti-obesity Prescription Sales Volume, by Type (2017-2028)
-
Table Europe Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Figure Europe Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Table Europe Anti-obesity Prescription Sales Volume, by Application (2017-2028)
-
Table Europe Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure Europe Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure Germany Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure UK Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure UK Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure France Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure France Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Italy Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Spain Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Poland Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Russia Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Table APAC Anti-obesity Prescription Sales Volume, by Type (2017-2028)
-
Table APAC Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Figure APAC Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Table APAC Anti-obesity Prescription Sales Volume, by Application (2017-2028)
-
Table APAC Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure APAC Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Japan Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure India Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure India Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Anti-obesity Prescription Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-obesity Prescription Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-obesity Prescription Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-obesity Prescription Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Anti-obesity Prescription Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Anti-obesity Prescription Sales Value and Growth Rate (2017-2028)
-
Table Zealand Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Zealand Pharma Product Profiles, Application and Specification
-
Table Zealand Pharma Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Akrimax Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Akrimax Pharmaceuticals Product Profiles, Application and Specification
-
Table Akrimax Pharmaceuticals Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Arrowhead Research Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arrowhead Research Product Profiles, Application and Specification
-
Table Arrowhead Research Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alpex Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alpex Pharma Product Profiles, Application and Specification
-
Table Alpex Pharma Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bridge BioResearch Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bridge BioResearch Product Profiles, Application and Specification
-
Table Bridge BioResearch Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Arena Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arena Pharmaceuticals Product Profiles, Application and Specification
-
Table Arena Pharmaceuticals Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Compellis Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Compellis Pharmaceuticals Product Profiles, Application and Specification
-
Table Compellis Pharmaceuticals Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Zydus Cadila Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Zydus Cadila Product Profiles, Application and Specification
-
Table Zydus Cadila Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Yungjin Pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Yungjin Pharm Product Profiles, Application and Specification
-
Table Yungjin Pharm Anti-obesity Prescription Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
